The real costs in the Ensign Group scandal may not be measured in dollars. They will be measured in days of missed physical therapy, in unattended bed alarms, in the slow decline of elderly patients who needed more care than they got. That is the human arithmetic behind the securities fraud investigation now underway.
Bleichmar Fonti & Auld LLP is looking at whether Ensign misled investors. But the underlying allegation, laid out in a June 8 research report from Hunterbrook Capital, is simpler and starker: Ensign made money by giving patients less care than they needed.
The company runs skilled nursing homes, senior living centers, and rehab facilities across the country. Its business model depends on government money — Medicare and Medicaid reimbursements. Tax dollars flow in.
The question is what flows out. Hunterbrook Capital alleged that Ensign padded its profit margins by understaffing its facilities.
At the same time, the company routed government payments to affiliate entities it owned or controlled. The result, according to the report: Ensign provided less care than it was supposed to provide, based on the tax dollars it received. That is not a regulatory technicality.
That is a nursing home resident lying in bed waiting for help that does not come. That is a family member visiting and finding a parent unwashed, unfed, or worse. The stock market reacted fast.
On June 8, Ensign shares dropped sharply. By nightfall, the damage was done.
Investors lost money. But the patients and their families lost something else — trust, and possibly their health. The investigation by Bleichmar Fonti & Auld is focused on securities law.
Did Ensign lie to shareholders about the quality of care at its facilities? Did it misrepresent its growth, its margins, its regulatory compliance?
Those are questions for the courts. But the stakes go beyond any one lawsuit. Ensign operates a network of facilities that house vulnerable people.
Skilled nursing and senior living are not abstract industries. They are places where people spend their last years, their last months, their last days. If the allegations are true, Ensign was cutting corners in those places to boost its bottom line.
Medicare and Medicaid are public programs. They are funded by taxpayers.
The idea is that the government pays private companies to provide a certain standard of care. If a company takes that money and provides less care than it promised, the system breaks. Patients suffer.
Taxpayers get cheated. The Hunterbrook report claimed Ensign’s profits could be traced directly to providing less care than patients needed.
That is a specific, damning allegation. It suggests that understaffing was not a mistake or a temporary problem. It was a strategy.
On the ground, residents and families at Ensign facilities are likely worried. They have to wonder: Was mom getting enough help? Was dad’s rehab shortchanged?
The investigation will take time. The answers may not come quickly.
Wall Street has already rendered its verdict, at least for now. The stock price fell hard on June 8. Investors who bought Ensign shares based on rosy statements about quality and compliance are now facing real losses.
The law firm is asking them to come forward. But the full toll of this scandal will not show up in any stock chart.
It will show up in patient outcomes, in family grief, in the quiet erosion of trust in a system meant to care for the elderly and the sick. That is what is genuinely at risk here. That is why this matters.
